Post by Roche Sequencing USA

It’s almost time to join a new beginning in next generation sequencing with AXELIOS 1! Discover more at the AGBT 2026 General Meeting from February 23– 26, you can find us in the Jade Lexington Suite. We’ll be revealing new research application highlights and developments that have never been shared before. Join us at our evening event, one of our two in-suite sessions, and our workshop featuring: Prof. dr. Edwin Cuppen, Scientific Director of the Hartwig Medical Foundation Along with experts from Roche Diagnostics Solutions: -Mitu Chaudhary, International Business Leader, Sequencing Systems -Gustav Karlberg, Lifecycle Leader, Sequencing Systems -Johanna Whitacre, Network Lead, Sequencing R&D -Mark Kokoris, Head of SBX Technology Get set to explore the world of AXELIOS 1. Find out more: https://spkl.io/6040AQskw The AXELIOS 1 sequencing platform and sequencing by expansion (SBX) technology are in development and not commercially available. The content of this material reflects current study results and/ or design goals. The AXELIOS 1 sequencing platform based on SBX technology will be launched for Research Use Only. Not for use in diagnostic procedures. AXELIOS is a trademark of Roche. #Genomics #AGBT #NextGenSequencing #Innovation #RocheSBX